Abstract:Background: Carcinoembryonic antigen CEA) can reflect tumor growth, recurrence and metastasis, and also predict the clinical efficacy of the epidermal growth factor receptor tyrosine kinase inhibitors EGFR-TKI). In the present study, we investigated the association between CEA in serum and pleural effusion PE) and EGFR mutations in patients with lung adenocarcinoma. Methods: We retrospectively investigated 114 lung adenocarcinoma patients with malignant pleural effusion MPE). CEA levels in serum and MPE were measured by immunoradiometric assay, we analysed the correlation between CEA and EGFR mutation status. Results: Fifty-three cases had EGFR mutation 46.5%). EGFR mutations were more common in females, patients with high levels of PE (>= 107.2 ng/mL) and serum CEA (>= 87 ng/mL). There was no significant difference in EGFR mutation rate between in tumor tissue and PE samples 49.3% vs. 41.9%, P=0.440). The result of receiver operating characteristic ROC) indicated that the cut off value of CEA in MPE was 107.2 ng/mL, which had the highest sensitivity SEN) and specificity SPE) for predicting EGFR mutation [SEN 66%, and SPE 62.3%, AUC =0.668, 95% confidence interval CI): 0.569-0.767, P=0.025]. The combination of gender, smoking history, serum and MPE CEA level had a higher calculated AUC 0.718, 95% CI: 0.622-0.813, P=0.000). Moreover, multivariate analysis showed that CEA level in MPE but not in serum was confirmed as the only independent factor associated with EGFR gene mutation status P=0.026) with an odds ratio of 2.885 95% CI: 1.137-7.317). Conclusions: MPE CEA can probably serve as a predictive marker for EGFR mutation in advanced lung adenocarcinoma. Combining gender, smoking history, and CEA has a relatively better predictive value. However, detecting EGFR mutations in lung adenocarcinomas is necessary for determining EGFR-TKI treatment in clinic.

Salivary Carcinoembryonic Antigen (CEA) in Cystic Fibrosis

A joint detection of CEA and CA-50 levels in saliva and serum of patients with tumors in oral region and salivary gland

Elevated Carcinoembryonic Antigen Predicts Rapidly Progressive Interstitial Lung Disease in Clinically Amyopathic Dermatomyositis

Revisiting the performance of cyst fluid carcinoembryonic antigen as a diagnostic marker for pancreatic mucinous cysts: a comprehensive 20-year institutional review

Gastric Acid Hypersecretion in Cystic Fibrosis

Expression of Carcinoembryonic Cell Adhesion Molecule 6 and Alveolar Epithelial Cell Markers in Lungs of Human Infants with Chronic Lung Disease

Expression of Cancer Cell-Derived IgG and Extra Domain A-containing Fibronectin in Salivary Adenoid Cystic Carcinoma.

A Study of CEA and CA-50 Levels in Saliva and Serum of Patients with Tumors in Oral Region and Salivary Gland

CEA in tumors of other than colorectal origin

Pathophysiology of cystic fibrosis with emphasis on salivary gland involvement

Hyperacidity of secreted fluid from submucosal glands in early cystic fibrosis.

Expression and Significance of Cyr61 in Distant Metastasis Cells of Human Primary Salivary Adenoid Cystic Carcinoma

Serum CEA levels in 49 different types of cancer and noncancer diseases

Serum-derived carcinoembryonic antigen (CEA) activates fibroblasts to induce a local re-modeling of the extracellular matrix that favors the engraftment of CEA-expressing tumor cells

Mucin Glycosylation Changes in Cystic Fibrosis Lung Disease Are Not Manifest in Submucosal Gland Secretions.

Abnormal pancreatic electrolyte secretion in cystic fibrosis. Reliability as a diagnostic marker

Clinical significance of CEA and CK20 expression in exfoliated cells by fiberoptic bronchoscopy brushing

Calcitonin Gene-Related Peptide Level in Cystic Fibrosis Patients

Carcinoembryonic Antigen in Pleural Effusion of Patients with Lung Adenocarcinoma: a Predictive Marker for EGFR Mutation

Elevated CEACAM5 Levels in Patients with Asthma

Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis